Intellectual Property India Publishes Patent Application for 'Pharmaceutically Acceptable Salt Of Compound And Preparation Method Therefor' Filed by Jiangsu Chia Tai Fenghai Pharmaceutical Co. Ltd.

MUMBAI, India, Aug. 29 -- Intellectual Property India has published a patent application (202517075782 A) filed by Jiangsu Chia Tai Fenghai Pharmaceutical Co. Ltd., Jiangsu, China, on Aug. 8, for 'pharmaceutically acceptable salt of compound and preparation method therefor.'

Inventor(s) include Zhu, Yongqiang; Chen, Qi; Tang, Sen; Yu, Qince; Liu, Jia; and Li, Chenhui.

The application for the patent was published on Aug. 29, under issue no. 35/2025.

According to the abstract released by the Intellectual Property India: "A base addition salt of a compound represented by formula (I) and a salt crystal form thereof, a preparation method therefor and a use thereof, as well as a pharmaceutical composition containing a therapeutically effective amount of the salt or crystal form and a use thereof in the treatment of ischemic brain injury-related diseases, spinal cord injuries, and neurodegenerative diseases."

The patent application was internationally filed on Jan. 09, 2024, under International application No.PCT/CN2024/071292.

Disclaimer: Curated by HT Syndication.